Allergan has agreed to hold a special shareholders' meeting on Dec. 18 in return for Pershing Square Capital Management and Valeant Pharmaceuticals dismissing their legal claims against the company
To continue reading this article subscribe now
If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.
Site powered by Webvision Cloud